Status:
COMPLETED
MINDSPACE Strategy for Risk Optimization
Lead Sponsor:
Indiana Institute for Medical Research
Collaborating Sponsors:
Genentech, Inc.
Regenstrief Institute, Inc.
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to find out which types of written stroke messages may help high risk stroke patients take action to improve their health.
Detailed Description
In this project, the investigators will draw on the science that has provided a foundation for behavioral economics as a guide to activation interventions. Specifically, the investigators will use the...
Eligibility Criteria
Inclusion
- • High risk stroke patients 18 years of age or older, as determined by calculation of a Framingham Stroke Risk Score
- At least one primary care visit 12 months prior to study initiation with the Richard L. Roudebush VA Medical Center (VHA) or Sidney \& Lois Eskenazi (EHS) Health System primary care clinics
Exclusion
- • Patients with at least one primary care provider visit in the prior 12 months in both the VA and EHS systems
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
641 Patients enrolled
Trial Details
Trial ID
NCT02721446
Start Date
June 1 2016
End Date
August 1 2018
Last Update
August 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Richard L. Roudebush VA Medical Center
Indianapolis, Indiana, United States, 46202